Advertisement
Singapore markets open in 3 hours 40 minutes

  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Bitcoin USD

    66,297.73
    -237.95 (-0.36%)
     

  • CMC Crypto 200

    1,426.91
    +12.15 (+0.86%)
     

  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     

  • Gold

    2,335.70
    -10.70 (-0.46%)
     

  • Crude Oil

    83.40
    +1.50 (+1.83%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     

  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     

  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     

  • Jakarta Composite Index

    7,110.81
    -7,073.82 (-49.87%)
     

  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Incyte (INCY) Looks Good: Stock Moves 10.9% Higher

Zacks Equity Research

Incyte Corporation (INCY) was a big mover last session with its shares rising nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained nearly 31% in the past one-month time frame.

This biopharmaceutical company has seen two positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has, however, remained unchanged over the same period. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Incyte currently has a Zacks Rank #2 (Buy) and its Earnings ESP is negative.

Investors interested in the biomedical industry may also consider stocks like Medivation, Inc. (MDVN), Illumina Inc. (ILMN) and Biogen Idec Inc. (BIIB). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




INCYTE GENOMICS INC (INCY): Free Stock Analysis Report

MEDIVATION INC (MDVN): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report


Zacks Investment Research